ROCKET PHARMACEUTICALS, INC. - RCKT

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Feb 20, 2026 CEO S D 5,990.0 3.338 19,994.62 1,046,055.0 View
Feb 20, 2026 See Remarks S D 1,157.0 3.338 3,862.07 91,019.0 View
Feb 20, 2026 General Counsel S D 1,376.0 3.338 4,593.09 682,000.0 View
Feb 18, 2026 CEO S D 12,279.0 3.312 40,668.05 1,052,045.0 View
Feb 18, 2026 See Remarks S D 3,726.0 3.312 12,340.51 92,176.0 View
Feb 18, 2026 General Counsel S D 12,253.0 3.312 40,581.94 683,376.0 View
Feb 13, 2026 Chief Operating Officer A A 93,037.0 0.0 0.0 93,037.0 View
Feb 13, 2026 Chief Operating Officer A A 61,963.0 0.0 0.0 469,129.0 View
Feb 13, 2026 Chief Medical Officer A A 93,037.0 0.0 0.0 93,037.0 View
Feb 13, 2026 Chief Medical Officer A A 61,963.0 0.0 0.0 407,874.0 View
Feb 13, 2026 General Counsel A A 468,187.0 0.0 0.0 468,187.0 View
Feb 13, 2026 General Counsel A A 311,813.0 0.0 0.0 695,629.0 View
Feb 13, 2026 See Remarks A A 45,018.0 0.0 0.0 45,018.0 View
Feb 13, 2026 See Remarks A A 29,982.0 0.0 0.0 95,902.0 View
Feb 13, 2026 CEO A A 870,648.0 0.0 0.0 870,648.0 View
Feb 13, 2026 CEO A A 286,028.0 0.0 0.0 1,064,324.0 View
Feb 13, 2026 See Remarks A A 189,076.0 0.0 0.0 189,076.0 View
Feb 13, 2026 See Remarks A A 125,924.0 0.0 0.0 285,160.0 View
Jan 06, 2026 P A 10,000.0 3.44 34,400.0 50,000.0 View
Nov 20, 2025 CEO S D 6,276.0 2.983 18,721.31 778,296.0 View
Nov 20, 2025 See Remarks S D 1,086.0 2.983 3,239.54 65,920.0 View
Nov 20, 2025 See Remarks S D 2,545.0 2.983 7,591.74 299,064.0 View
Nov 20, 2025 General Counsel S D 1,646.0 2.983 4,910.02 383,816.0 View
Nov 10, 2025 General Counsel A A 100,000.0 0.0 0.0 385,462.0 View